164 related articles for article (PubMed ID: 35008098)
1. The CLL comorbidity index in a population-based cohort: a tool for clinical care and research.
Rotbain EC; Gordon MJ; Vainer N; Frederiksen H; Hjalgrim H; Danilov AV; Niemann CU
Blood Adv; 2022 Apr; 6(8):2701-2706. PubMed ID: 35008098
[TBL] [Abstract][Full Text] [Related]
2. The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.
Gordon MJ; Kaempf A; Sitlinger A; Shouse G; Mei M; Brander DM; Salous T; Hill BT; Alqahtani H; Choi M; Churnetski MC; Cohen JB; Stephens DM; Siddiqi T; Rivera X; Persky D; Wisniewski P; Patel K; Shadman M; Park B; Danilov AV
Clin Cancer Res; 2021 Sep; 27(17):4814-4824. PubMed ID: 34168050
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the CLL-IPI and IPS-E Prognostic Indices in a Young Middle Eastern Population with Chronic Lymphocytic Leukemia: A Retrospective Analysis at the Kuwait Cancer Control Center.
Alshemmari SH; Alsarraf A; Kunhikrishnan A; Pandita R
Med Princ Pract; 2023; 32(3):192-199. PubMed ID: 37517397
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of chronic lymphocytic leukemia comorbidity index in a young population: a real-world evidence study of a national gulf region cohort.
Alshemmari SH; AlSarraf A; Kaempf A; Danilov AV
BMC Cancer; 2024 May; 24(1):584. PubMed ID: 38741031
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.
Gordon MJ; Churnetski M; Alqahtani H; Rivera X; Kittai A; Amrock SM; James S; Hoff S; Manda S; Spurgeon SE; Choi M; Cohen JB; Persky D; Danilov AV
Cancer; 2018 Aug; 124(15):3192-3200. PubMed ID: 29797667
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study.
Duchesneau ED; McNeill AM; Schary W; Pate V; Lund JL
J Geriatr Oncol; 2023 Nov; 14(8):101602. PubMed ID: 37696241
[TBL] [Abstract][Full Text] [Related]
7. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
[TBL] [Abstract][Full Text] [Related]
8. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
9. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
10. Treatment of elderly patients with chronic lymphocytic leukemia.
Eichhorst B; Goede V; Hallek M
Leuk Lymphoma; 2009 Feb; 50(2):171-8. PubMed ID: 19197731
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia.
Farren TW; Giustiniani J; Fanous M; Liu F; Macey MG; Wright F; Prentice A; Nathwani A; Agrawal SG
Blood Cancer J; 2015 Jan; 5(1):e273. PubMed ID: 25615279
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
Kim HT; Ahn KW; Hu ZH; Davids MS; Volpe VO; Antin JH; Sorror ML; Shadman M; Press O; Pidala J; Hogan W; Negrin R; Devine S; Uberti J; Agura E; Nash R; Mehta J; McGuirk J; Forman S; Langston A; Giralt SA; Perales MA; Battiwalla M; Hale GA; Gale RP; Marks DI; Hamadani M; Ganguly S; Bacher U; Lazarus H; Reshef R; Hildebrandt GC; Inamoto Y; Cahn JY; Solh M; Kharfan-Dabaja MA; Ghosh N; Saad A; Aljurf M; Schouten HC; Hill BT; Pawarode A; Kindwall-Keller T; Saba N; Copelan EA; Nathan S; Beitinjaneh A; Savani BN; Cerny J; Grunwald MR; Yared J; Wirk BM; Nishihori T; Chhabra S; Olsson RF; Bashey A; Gergis U; Popat U; Sobecks R; Alyea E; Saber W; Brown JR
Clin Cancer Res; 2019 Aug; 25(16):5143-5155. PubMed ID: 31253630
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
[TBL] [Abstract][Full Text] [Related]
15. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Leis JF; Kenderian SS; Muchtar E; Wang Y; Koehler AB; Schwager SM; Lesnick CE; Kleinstern G; Van Dyke D; Hanson CA; Braggio E; Slager SL; Shanafelt TD
Blood; 2021 Jul; 138(2):149-159. PubMed ID: 33876228
[TBL] [Abstract][Full Text] [Related]
16. Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
Turcsanyi P; Kriegova E; Kudelka M; Radvansky M; Kruzova L; Urbanova R; Schneiderova P; Urbankova H; Papajik T
Leuk Res; 2019 Apr; 79():60-68. PubMed ID: 30852300
[TBL] [Abstract][Full Text] [Related]
17. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.
Soumerai JD; Ni A; Darif M; Londhe A; Xing G; Mun Y; Kay NE; Shanafelt TD; Rabe KG; Byrd JC; Chanan-Khan AA; Furman RR; Hillmen P; Jones J; Seymour JF; Sharman JP; Ferrante L; Mobasher M; Stark T; Reddy V; Dreiling LK; Bhargava P; Howes A; James DF; Zelenetz AD
Lancet Haematol; 2019 Jul; 6(7):e366-e374. PubMed ID: 31109827
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study.
Villavicencio A; Solans M; Zacarías-Pons L; Vidal A; Puigdemont M; Roncero JM; Saez M; Marcos-Gragera R
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467494
[TBL] [Abstract][Full Text] [Related]
19. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.
Cooper JP; Khajaviyan S; Smith SD; Maloney DG; Shustov AR; Warren EH; Soma LA; Lynch RC; Ujjani C; Till B; Halpern AB; Gopal AK; Deeg HJ; Scott BL; Shadman M
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):390-395. PubMed ID: 30948330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
